Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natalizumab Extension Study in MS
NCT00276172Phase 3Completed
- Sponsor
- Biogen
- Start
- Dec 2003
- Primary completion
- Oct 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of natalizumab in multiple sclerosis (MS), sponsored by Biogen. Started Dec 2003; status: completed.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00276172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276172.